Invests in
Locations:
Min Investment:
$100,000.00Max Investment:
$5,000,000.00Target Investment:
$1,500,000.00
Education
- LU
Lists including Roel
Investments
iOnctura
Total Funding: $110M
QurAlis
Total Funding: $140M
NMD Pharma
Total Funding: $40M
Salvia BioElectronics
Total Funding: $31M
VarmX
Total Funding: $83M
Comet Therapeutics
Total Funding: $29M
aveni
Total Funding: $10M
Bird Rock Bio
Total Funding: $61M
F-Star Therapeutics
Total Funding: $53M
Work Experience
2023
Managing Partner
2023
2023 - 2023
Enjoying the sun
2023 - 2023
2019 - 2023
Managing Director
2019 - 2023
2009 - 2018
Senior Vice President & Managing Director
2015 - 2018
We drive innovation and back entrepreneurs through equity investments and hands on support in fields that could impact the vitality and sustainability of Merck’s current and future businesses. We are the strategic, corporate venture capital arm of Merck. Our mandate is to invest in innovative technologies and products with the potential to significantly impact Merck’s core business areas. From our headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by great entrepreneurs. We take an active role in our portfolio companies and team up with entrepreneurs and co-investors to translate innovation towards commercial success. We have a significant focus on early stage investing and company creation including the creation of spin-offs to leverage Merck’s science and technology base.
Senior Vice President & Managing Director
2009 - 2018
2007 - 2015
Senior Director, Head of Merck Serono Ventures
2009 - 2015
Director, Head of Venture Capital Scouting
2007 - 2009
2006 - 2007
Associate Director, Corporate M&A
2006 - 2007
2000 - 2005
Director-Biotechnology Investment Banking
2000 - 2005
2000 - 2000
Business Development
2000 - 2000